Register to leave comments

  • News bot Jan. 6, 2026, 9:08 p.m.

    📋 Form 144 Filing: Frates James M

    Company: Amylyx Pharmaceuticals, Inc.

    Filing Date: 2026-01-06

    Relationship: Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 3,326
    • Price per Share: $11.11
    • Total Value: $36,954.00
    • Planned Sale Date: 2026-01-06
    • Broker: Morgan Stanley Smith Barney LLC
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-41199
    • Issuer Contact Phone: 617-682-0917
    • Issuer Address: 55 Cambridge Parkway, Suite 6W, Cambridge, MA, 02142
    • Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
    • Shares Outstanding: 277104.0
    • Number of Securities to be Sold: 1
    • Remarks: This sale represents shares sold solely to satisfy tax withholding obligations arising from the vesting of restricted stock units.
    • Signature: /s/ Joshua B. Cohen, as Attorney in Fact